BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6491670)

  • 1. Degradation of NAD by synaptosomes and its inhibition by nicotinamide mononucleotide: implications for the role of NAD as a synaptic modulator.
    Snell CR; Snell PH; Richards CD
    J Neurochem; 1984 Dec; 43(6):1610-5. PubMed ID: 6491670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereospecific binding sites for [3H]nicotinamide adenine dinucleotide in the rat brain.
    Snell PH; Snell CR; Richards CD
    Eur J Pharmacol; 1985 Oct; 116(1-2):121-7. PubMed ID: 4054211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotinamide adenine dinucleotide depresses synaptic transmission in the hippocampus and has specific binding sites on the synaptic membranes.
    Richards CD; Snell CR; Snell PH
    Br J Pharmacol; 1983 Jun; 79(2):553-64. PubMed ID: 6317113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotinamide mononucleotide inhibits post-ischemic NAD(+) degradation and dramatically ameliorates brain damage following global cerebral ischemia.
    Park JH; Long A; Owens K; Kristian T
    Neurobiol Dis; 2016 Nov; 95():102-10. PubMed ID: 27425894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Release, neuronal effects and removal of extracellular β-nicotinamide adenine dinucleotide (β-NAD⁺) in the rat brain.
    Durnin L; Dai Y; Aiba I; Shuttleworth CW; Yamboliev IA; Mutafova-Yambolieva VN
    Eur J Neurosci; 2012 Feb; 35(3):423-35. PubMed ID: 22276961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Properties of NAD binding by synaptic membranes of rat brain].
    Khalmuradov AG; Parkhomets PK; Kuchmerovskaia TM; Chichkovskaia GV
    Biokhimiia; 1983 Aug; 48(8):1287-92. PubMed ID: 6626596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-targeted Effect of Nicotinamide Mononucleotide on Brain Bioenergetic Metabolism.
    Klimova N; Kristian T
    Neurochem Res; 2019 Oct; 44(10):2280-2287. PubMed ID: 30661231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific binding of crotoxin to brain synaptosomes and synaptosomal membranes.
    Degn LL; Seebart CS; Kaiser II
    Toxicon; 1991; 29(8):973-88. PubMed ID: 1949068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of nicotinamide mononucleotide on brain mitochondrial respiratory deficits in an Alzheimer's disease-relevant murine model.
    Long AN; Owens K; Schlappal AE; Kristian T; Fishman PS; Schuh RA
    BMC Neurol; 2015 Mar; 15():19. PubMed ID: 25884176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotinamide mononucleotide protects against β-amyloid oligomer-induced cognitive impairment and neuronal death.
    Wang X; Hu X; Yang Y; Takata T; Sakurai T
    Brain Res; 2016 Jul; 1643():1-9. PubMed ID: 27130898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of nicotinamide adenine dinucleotide on the serotoninergic mediator system in the rat brain during 3-acetylpyridine administration].
    Kuchmerovskaia TM; Chichkovskaia GV; Pakirbaeva LV; Khalmuradov AA
    Vopr Med Khim; 2002; 48(3):264-70. PubMed ID: 12243084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nicotinamide Mononucleotide Administration Prevents Experimental Diabetes-Induced Cognitive Impairment and Loss of Hippocampal Neurons.
    Chandrasekaran K; Choi J; Arvas MI; Salimian M; Singh S; Xu S; Gullapalli RP; Kristian T; Russell JW
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32466541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of endothelial dysfunction by nicotinamide mononucleotide via extracellular conversion to nicotinamide riboside.
    Mateuszuk Ł; Campagna R; Kutryb-Zając B; Kuś K; Słominska EM; Smolenski RT; Chlopicki S
    Biochem Pharmacol; 2020 Aug; 178():114019. PubMed ID: 32389638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral Administration of Nicotinamide Mononucleotide Increases Nicotinamide Adenine Dinucleotide Level in an Animal Brain.
    Ramanathan C; Lackie T; Williams DH; Simone PS; Zhang Y; Bloomer RJ
    Nutrients; 2022 Jan; 14(2):. PubMed ID: 35057482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NAMPT inhibitor and metabolite protect mouse brain from cryoinjury through distinct mechanisms.
    Zhang XQ; Lu JT; Jiang WX; Lu YB; Wu M; Wei EQ; Zhang WP; Tang C
    Neuroscience; 2015 Apr; 291():230-40. PubMed ID: 25684751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotinamide mononucleotide preserves mitochondrial function and increases survival in hemorrhagic shock.
    Sims CA; Guan Y; Mukherjee S; Singh K; Botolin P; Davila A; Baur JA
    JCI Insight; 2018 Sep; 3(17):. PubMed ID: 30185676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Administration of Nicotinamide Mononucleotide Mitigates Age-Associated Physiological Decline in Mice.
    Mills KF; Yoshida S; Stein LR; Grozio A; Kubota S; Sasaki Y; Redpath P; Migaud ME; Apte RS; Uchida K; Yoshino J; Imai SI
    Cell Metab; 2016 Dec; 24(6):795-806. PubMed ID: 28068222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyridine nucleotide cycle of Salmonella typhimurium: in vitro demonstration of nicotinamide adenine dinucleotide glycohydrolase, nicotinamide mononucleotide glycohydrolase, and nicotinamide adenine dinucleotide pyrophosphatase activities.
    Foster JW
    J Bacteriol; 1981 Feb; 145(2):1002-9. PubMed ID: 6109709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicotinamide mononucleotide attenuates brain injury after intracerebral hemorrhage by activating Nrf2/HO-1 signaling pathway.
    Wei CC; Kong YY; Li GQ; Guan YF; Wang P; Miao CY
    Sci Rep; 2017 Apr; 7(1):717. PubMed ID: 28386082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of nicotinamide mononucleotide in beef liver.
    Imai T; Anderson BM
    Arch Biochem Biophys; 1987 Apr; 254(1):241-52. PubMed ID: 3034159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.